MedTrace Logo

Effects of Remote Ischemic Conditioning on Myocardial Perfusion in Humans

NCT02230098 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2015-01-16

No results posted yet for this study

Summary

Cardiovascular disease is the second leading cause of death in Denmark, and ischemic heart disease accounts for the bulk of it. The purpose of this study is to clarify whether a mechanical method of remote ischemic conditioning in the form of short-term obstruction of the blood supply to the arm, can improve the heart's blood supply in patients with ischemic heart disease. This will be attempted through experiments on patients with ischemic heart disease and experimental animal studies with simulated cardiovascular disease.

This study will help to clarify whether remote ischemic preconditioning can be used to treat patients with ischemic heart disease.

Conditions

  • Ischemic Heart Disease

Interventions

OTHER

Remote Ischemic Conditioning

Sponsors & Collaborators

  • Leducq Foundation

    collaborator OTHER

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Roni Ranghøj Nielsen, MD, PhD · Department of Cardiology, Aarhus University Hospital

  • Hans Erik Bøtker, Prof, MD, PhD, DMSc · Dept. of Cardiology, Aarhus University Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02230098 on ClinicalTrials.gov